Drug
Levamlodipine clinical trials
- studies test it
- 17
- open now
- 1
- in phase 3
- 2
- first study started
- 2010
Keep track of what changes. Save the levamlodipine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 3
Chong Kun Dang Pharmaceutical (11) · Conjupro Biotherapeutics, Inc. (1) · Affiliated Hospital of North Sichuan Medical College (1) · The Affiliated Hospital of Qingdao University (1) · Neutec Ar-Ge San ve Tic A.Ş (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Seoul National University Bundang Hospital (1)
Often tested with
Tested in the same studies.
Telmisartan (10) · Rosuvastatin (9) · CKD-348 (8) · Ezetimibe (8) · Amlodipine (1)
Studies
Open first, then newest update. How each study uses levamlodipine is read from its arms, and is right about nine times in ten.
Testing it · 17
- A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsNot yet recruitingPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06771245Written as Levamlodipine
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT06112678Written as CKD-828, D097, D337
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04883658Written as CKD-828, D097, D337
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04660370Written as CKD-828, D097, D337
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05749861Written as CKD-828, D097, D337
- Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05549401Written as CKD-828, D097, D337
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05192356Written as CKD-828, D097, D337
- Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy SubjectsCompletedPhase 1Conjupro Biotherapeutics, Inc.NCT03657550Written as Levamlodipine, Amlodipine
- Anti Inflammatory Treatment of HypertensionCompletedPhase 2/3Affiliated Hospital of North Sichuan Medical CollegeNCT04740840Written as Levamlodipine
- A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04587206Written as CKD-828, D097, D337
- A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04258865Written as CKD-828, D097, D337
- Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese SubjectsCompletedPhase 1The Affiliated Hospital of Qingdao UniversityNCT04411875Written as Levamlodipine 5 mg
- Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension PatientsCompletedPhase 4Neutec Ar-Ge San ve Tic A.ŞNCT03038451Written as S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet
- S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in HypertensionStatus unknownPhase 4Seoul National University Bundang HospitalNCT03226340Written as S-amlodipine 2.5mg + Chlorthalidone 25mg
- CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02047175Written as Telmisartan/S-Amlodipine
- CKD-828 Drug Interaction Study (S-amlodipine)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT01356043Written as S-amlodipine 5mg,Telmisartan 80mg
- CKD-828 Primary Hypertension Trial(Dose-selection)CompletedPhase 2Chong Kun Dang PharmaceuticalNCT01128322Written as S-Amlodipine, Telmisartan
As the comparator · 5 — what is tested is compared with levamlodipine
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02358824Written as S-amlodipine
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02250833Written as S-amlodipine
- Efficacy and Safety of TELMINUVO to Stage 2 HypertensionStatus unknownPhase 3Chong Kun Dang PharmaceuticalNCT01983735Written as S-amlodipine 2.5mg
- Efficacy and Safety of CKD-828 to Stage 2 HypertensionCompletedPhase 3Chong Kun Dang PharmaceuticalNCT01634295Written as S-amlodipine 2.5mg
- CKD-828 S-Amlodipine Non-Responder TrialCompletedPhase 3Chong Kun Dang PharmaceuticalNCT01501253Written as S-Amlodipine 2.5mg
Codes
What other systems call levamlodipine · ClinicalTrials.gg INT005473
- MeSH (NLM) C542574levamlodipineOne source NLM
- UNII (FDA) 0P6NLP6806LEVAMLODIPINEConfirmed FDA, NLM, Wikidata
- RxNorm 2376944One source FDA
- Wikidata Q6534831levamlodipineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166430LevamlodipineOne source FDA
- DrugBank DB09237One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C542574 | levamlodipine | One source NLM |
| UNII (FDA) | 0P6NLP6806 | LEVAMLODIPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2376944 | — | One source FDA |
| Wikidata | Q6534831 | levamlodipine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166430 | Levamlodipine | One source FDA |
| DrugBank | DB09237 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.